
Artificial intelligence is poised to fundamentally accelerate biological discovery and longevity research, potentially enabling humanity to reach "longevity escape velocity" within the next decade. By integrating high-dimensional datasets—including genomics, proteomics, and real-time biometric monitoring—scientists can construct "digital twins" to simulate human physiology, allowing for rapid, personalized drug development and the reduction of clinical trial timelines from years to months. Beyond treating acute conditions, AI-driven preventative medicine offers the ability to identify disease trajectories, such as cancer or neurodegeneration, years before clinical onset. As AI models evolve to incorporate persistent memory and reasoning, they will function as essential clinical collaborators, reducing diagnostic errors and enabling precise, on-demand therapeutic protocols. This shift moves healthcare from a reactive model toward a proactive, data-driven system capable of engineering biological resilience and extending human healthspan.
Part 1: Longevity, AI, Superintelligence
Part 2: Clinical Practice, Diagnostics, Cancer
Part 3: Cellular Reprogramming, Brain Health
Part 4: Practical Applications
Sign in to continue reading, translating and more.
Open full episode in Podwise